Recruiting Fabry Disease Registry & Pregnancy Sub-registry NCT00196742 Conditions Angiokeratoma, Brain Diseases, Brain Diseases, Metabolic, +23 more Locations University of Alabama Birmingham- Nephrology- Site Number : 840018 — Birmingham, Alabama, United States University of Alabama Birmingham- Nephrology- Site Number : 840073 — Birmingham, Alabama, United States Phoenix Children's Hospital- Site Number : 840003 — Phoenix, Arizona, United States University of Arizona- Site Number : 840015 — Tucson, Arizona, United States View all 284 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU) NCT07552077 Conditions Angiokeratoma, Angiokeratomas, Neoplasms, +2 more Locations Unified Health — Sherman Oaks, California, United States Cleaver Medical Group — Dawsonville, Georgia, United States Vividia Dermatology — Las Vegas, Nevada, United States Epiphany Dermatology — Southlake, Texas, United States View Trial Details
Completed Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients NCT04804566 Conditions Angiokeratoma, Brain Diseases, Brain Diseases, Metabolic, +37 more Locations Engage Health — Eagan, Minnesota, United States View Trial Details
